Clinical Pathways
Trigeminal Neuralgia Case Review & Coordination
Structured facial pain review before a procedure decision
Trigeminal neuralgia is a clinical pain syndrome, but not every severe or one-sided facial pain pattern is trigeminal neuralgia. The first coordination task is to describe the attacks precisely, distinguish classical, idiopathic and secondary trigeminal neuralgia from painful trigeminal neuropathy and other facial pain disorders, review prior dental and medical investigations, and identify whether high-resolution imaging or a specialist re-evaluation is needed.
Healwise supports international patients and referring physicians by preparing complex trigeminal neuralgia and facial pain cases for neurological, neurosurgical, neuroradiological, pain medicine and orofacial review. We organize symptom history, trigger patterns, medication response, MRI and DICOM files, dental records, prior procedures, sensory changes, patient goals and follow-up questions into a review-ready case file.
Healwise does not diagnose trigeminal neuralgia, prescribe or change medication, determine eligibility for microvascular decompression or another procedure, or provide emergency pain care. Clinical diagnosis, treatment selection and risk-benefit decisions are made by licensed specialist teams.
When this pathway may be relevant
- Short, severe, electric-shock-like facial pain is triggered by touch, chewing, speaking, brushing teeth, washing the face or cold air.
- Carbamazepine, oxcarbazepine or another specialist-prescribed medication has become ineffective, poorly tolerated or difficult to use safely.
- MRI shows or is suspected to show neurovascular compression, multiple sclerosis, a posterior fossa lesion or another secondary cause.
- Microvascular decompression, radiofrequency treatment, balloon compression, glycerol rhizolysis or stereotactic radiosurgery has been discussed.
- Pain has returned after a previous procedure, or new numbness, burning pain or sensory disturbance has developed.
- The diagnosis is uncertain because pain is continuous, bilateral, associated with numbness, began after dental or facial trauma, or does not follow a typical trigeminal pattern.
- A rare salvage pathway such as peripheral trigeminal branch stimulation or Gasserian ganglion stimulation has been proposed.
Typical clinical questions
- Does the pain phenotype meet criteria for trigeminal neuralgia, or is another facial pain diagnosis more likely?
- Is the pattern purely paroxysmal, or is there concomitant continuous pain between attacks?
- Is there objective facial sensory loss, bilateral involvement, younger onset or another feature suggesting a secondary cause?
- Was the MRI performed with appropriate posterior fossa and trigeminal nerve sequences, and does it show clinically relevant neurovascular compression?
- Have first-line medicines been used appropriately, and are efficacy, adverse effects and safety monitoring documented?
- Would decompression, an ablative procedure, radiosurgery, continued medical management, or no procedure be the most appropriate discussion?
- If pain persists after prior nerve injury or destructive treatment, is this recurrent neuralgia, painful trigeminal neuropathy, deafferentation pain or another condition?
Urgent or expedited assessment
Some situations require local urgent or expedited medical assessment before international coordination.
- New facial weakness, marked sensory loss, double vision, hearing change, severe imbalance, limb weakness or another progressive neurological deficit.
- Sudden severe headache, altered consciousness, stroke-like symptoms or concern for an acute vascular event.
- Inability to eat, drink or take essential medication because attacks are continuous or extremely frequent.
- Severe medication toxicity, confusion, rash, fainting, marked unsteadiness or another concerning adverse effect.
- New facial pain with fever, infection, shingles involving the eye, cancer history, or rapid clinical deterioration.
- Suicidal thoughts, severe psychological distress or inability to remain safe because of uncontrolled pain.
In urgent or unstable situations, patients should contact local emergency or treating medical services first.
Documents usually needed for specialist review
The most useful file shows the exact pain phenotype, previous treatment response, imaging quality, sensory findings, prior procedures and the patient’s goals—not only the diagnostic label.
1. Pain history and attack profile
- Date and circumstances of onset.
- Side of the face and involved trigeminal divisions: forehead/eye region, cheek/upper jaw, or lower jaw.
- Attack quality, duration, frequency, clustering and pain-free intervals.
- Trigger zones and activities such as eating, speaking, touch, wind, oral hygiene or shaving.
- Presence of continuous background pain, burning, aching, numbness or allodynia between attacks.
- Pain diary, functional impact, sleep, nutrition, oral care and psychological impact.
- Smartphone notes or videos where they safely capture visible triggers or associated facial movements.
2. Medication and safety timeline
- Current and previous medicines, dose history, duration and reason for stopping.
- Degree and duration of pain control.
- Adverse effects, allergies, drug interactions and relevant laboratory monitoring where available.
- Rescue treatments used during severe exacerbations.
- Anticoagulants, antiplatelet medicines and other drugs relevant to procedural planning.
- Medication adherence and any difficulty eating, drinking or swallowing tablets during attacks.
3. MRI, DICOM and neuroradiology material
- Brain MRI and original DICOM files, preferably including high-resolution posterior fossa and trigeminal nerve sequences.
- Radiology report and any prior specialist neuroradiology review.
- MR angiographic or vascular sequences where performed.
- Previous imaging for comparison.
- Documentation of suspected neurovascular contact, nerve displacement or atrophy, multiple sclerosis plaques, tumour, vascular lesion or other secondary cause.
A generic brain MRI report may not answer the questions needed for a trigeminal neuralgia surgical review. The receiving team may request repeat or differently protocolled imaging.
4. Neurological, dental and orofacial records
- Neurological examination and documented facial sensation.
- Dental, maxillofacial, temporomandibular joint and ENT assessments where relevant.
- Records of root-canal treatment, extractions, implants, local anaesthetic blocks or other irreversible dental procedures.
- History of herpes zoster, facial trauma, sinus disease, migraine, cluster headache or other cranial neuralgia.
- Multiple sclerosis, autoimmune, oncological or infectious history where relevant.
5. Previous procedures and outcomes
- Operative reports for microvascular decompression.
- Details of radiofrequency thermocoagulation, balloon compression, glycerol rhizolysis or stereotactic radiosurgery.
- Target side, date, immediate result, duration of benefit and reason for recurrence.
- New facial numbness, corneal sensory change, dysesthesia, chewing weakness, hearing change, balance problem or other complication.
- Images and planning records where available.
- Records of prior peripheral nerve, trigeminal branch or Gasserian ganglion stimulation, including trial response, lead location, programming and device complications.
6. Medical fitness, expectations and follow-up plan
- Age, major medical conditions, previous anaesthesia and surgical history.
- Cardiovascular, respiratory, bleeding, infection and wound-healing risks.
- Baseline hearing, balance, facial sensation, corneal health and swallowing where relevant.
- Patient priorities: longest possible durability, avoidance of craniotomy, rapid recovery, preservation of facial sensation, or another goal.
- Travel support, family support and ability to remain near the treating centre after intervention.
- Access to local neurological, neurosurgical, ophthalmic, dental, pain and device follow-up.
How the coordination pathway works
The pathway should move from diagnosis clarification to an individualized treatment discussion—not from a website form directly to a procedure.
Major clinical distinctions and decision points
Different facial pain phenotypes can require completely different treatment strategies. A procedure appropriate for classical trigeminal neuralgia may be ineffective or harmful in another facial pain disorder.
1. Classical, idiopathic and secondary trigeminal neuralgia
Classical trigeminal neuralgia usually refers to a typical clinical syndrome with neurovascular compression of the trigeminal root and associated morphological nerve change. Idiopathic trigeminal neuralgia has the clinical phenotype without an identified structural cause. Secondary trigeminal neuralgia is attributable to another disease, such as multiple sclerosis or a space-occupying lesion. These categories influence imaging, counselling and treatment selection.
2. Purely paroxysmal pain versus concomitant continuous pain
Some patients have only brief, triggerable attacks; others also have continuous or near-continuous pain between attacks. Continuous background pain does not automatically exclude trigeminal neuralgia, but it can affect diagnostic confidence, expected response and counselling. Burning or persistent pain with sensory loss, especially after trauma or intervention, may instead indicate painful trigeminal neuropathy.
3. Imaging and clinically relevant neurovascular compression
MRI is used to look for secondary causes and to assess the trigeminal nerve and nearby vessels. A simple vessel–nerve contact is common and does not by itself prove causation. Specialist review considers the side and site of contact, nerve distortion or atrophy, the pain phenotype, and whether the imaging finding is concordant with symptoms. Imaging quality and protocol matter.
4. Medication pathway
Carbamazepine or oxcarbazepine is commonly used as first-line long-term medication for classical trigeminal neuralgia. Other medicines or combinations may be considered by specialists if first-line treatment is ineffective, poorly tolerated or contraindicated. Medication history should document both benefit and adverse effects. Patients should not stop or change treatment without clinical guidance, particularly during a severe exacerbation.
5. Microvascular decompression
Microvascular decompression treats suspected neurovascular compression without intentionally damaging the trigeminal nerve. It may be discussed for medically suitable patients with a convincing classical phenotype and concordant imaging, particularly when medication no longer provides an acceptable balance of benefit and burden. It requires posterior fossa surgery and carries anaesthetic and surgical risks, including cerebrospinal-fluid leak, hearing or balance change, facial sensory or motor complications, infection, vascular injury and recurrence.
6. Percutaneous Gasserian ganglion procedures
Radiofrequency thermocoagulation, balloon compression and glycerol rhizolysis reach the trigeminal system percutaneously and intentionally alter pain-transmitting fibres. They may be considered when a shorter or less invasive procedure is preferred, when medical fitness makes open surgery less suitable, or after recurrence. The trade-off is a greater likelihood of facial numbness and risks such as dysesthesia, corneal sensory loss, chewing weakness, recurrence and, rarely, painful deafferentation or anaesthesia dolorosa. The risk profile differs by technique and affected trigeminal division.
7. Stereotactic radiosurgery
Stereotactic radiosurgery delivers focused radiation to the trigeminal root. It avoids an incision and general anaesthesia may not be required, but pain relief is typically delayed rather than immediate. Facial numbness, incomplete response and recurrence can occur, and future procedure planning should take prior radiation into account. It is not equivalent to microvascular decompression or a percutaneous procedure; each option has different timing, durability and risk considerations.
8. Multiple sclerosis and other secondary causes
Patients with multiple sclerosis, bilateral symptoms, younger onset, objective sensory loss or atypical neurological findings require careful secondary-cause evaluation. Treatment may include disease-specific management as well as trigeminal neuralgia medication or procedures. Outcomes and recurrence patterns can differ from classical neurovascular-compression cases, and an apparent vascular contact may coexist with central demyelination.
9. Recurrent pain after previous treatment
Recurrent facial pain should not automatically trigger repetition of the same procedure. Review should ask whether the original diagnosis remains correct, how long the prior benefit lasted, whether imaging or pain distribution has changed, and whether sensory injury or a new pain phenotype developed. Options may include medication review, repeat decompression, another percutaneous technique, radiosurgery, secondary-cause assessment or non-ablative pain pathways.
10. Painful trigeminal neuropathy and deafferentation pain
Continuous burning, aching, allodynia or painful numbness after dental injury, facial trauma, herpes zoster, surgery or an ablative trigeminal procedure is not the same as classical trigeminal neuralgia. Further destructive procedures may worsen sensory loss or deafferentation pain. These cases often need a multidisciplinary neuropathic facial pain pathway, careful medication review, sensory documentation, psychological and functional support, and highly selective consideration of neuromodulation.
11. Gasserian ganglion stimulation and other neuromodulation
Gasserian, or trigeminal, ganglion stimulation is not a routine guideline-supported treatment for classical trigeminal neuralgia and should not be presented as equivalent to microvascular decompression, percutaneous rhizotomy or radiosurgery. Published clinical evidence remains limited and largely concerns highly refractory trigeminal neuropathic or deafferentation facial pain, including some patients with previous nerve injury or unsuccessful destructive treatment.
Where a highly experienced specialist centre considers it, the pathway should be framed as case-by-case salvage neuromodulation. Evaluation may include confirmation of the pain phenotype, documentation of existing sensory loss, review of previous procedures, realistic functional goals, technical feasibility, infection and bleeding risk, and a temporary or staged stimulation assessment depending on the technique and local practice. Long-term care requires programming, hardware surveillance and access to revision or explant services. Possible problems include infection, lead migration, hardware failure, unpleasant stimulation, incomplete benefit and loss of effect.
Peripheral trigeminal branch stimulation is a related but anatomically different approach and may be considered for selected focal neuropathic facial pain patterns. Neither approach should be marketed as an established cure for trigeminal neuralgia.
12. Dental and other facial pain mimics
Dental disease, temporomandibular disorders, persistent idiopathic facial pain, post-traumatic trigeminal neuropathy, postherpetic neuralgia, migraine, trigeminal autonomic cephalalgias, sinus or ENT disease and other cranial neuralgias can mimic or coexist with trigeminal neuralgia. Repeated irreversible dental procedures should be avoided when the pain phenotype and dental findings do not align. Orofacial pain, dental, neurological and imaging input may all be needed.
Treatment pathways that may be discussed
The appropriate pathway depends on diagnostic confidence, pain phenotype, imaging, medical fitness, previous treatment, sensory function, patient priorities and expected follow-up.
Diagnostic and medical optimization
Some patients need repeat clinical classification, high-resolution MRI, neuroradiology review, dental or orofacial evaluation, secondary-cause investigation, medication adjustment, adverse-effect monitoring or acute exacerbation planning before a procedure should be considered.
Decompression, percutaneous treatment or radiosurgery
Selected patients may be assessed for microvascular decompression, radiofrequency thermocoagulation, balloon compression, glycerol rhizolysis or stereotactic radiosurgery. These options differ in invasiveness, speed of relief, durability, recurrence and risk of facial sensory change.
Refractory neuropathic facial pain pathway
When the phenotype is painful trigeminal neuropathy or deafferentation pain rather than classical neuralgia, the team may discuss multidisciplinary pain care and, in rare highly selected cases, peripheral trigeminal branch or Gasserian ganglion stimulation. The evidence base is limited and long-term device care is essential.
Recovery, sensory monitoring and long-term follow-up
A procedure does not end the pathway. Pain recurrence, sensory change, medication use and functional recovery need structured follow-up.
Early recovery
- Wound, pin-site or puncture-site review according to procedure.
- Facial sensation, corneal symptoms, chewing, hearing and balance monitoring.
- Medication continuation or tapering only under specialist guidance.
- Hydration, nutrition and oral-care support after severe attacks.
- Clear instructions for new neurological symptoms, fever, wound problems or uncontrolled pain.
Outcome tracking
- Attack frequency, severity, triggers and pain-free intervals.
- Continuous background pain and sensory symptoms.
- Medication burden and adverse effects.
- Eating, drinking, speaking, oral hygiene, sleep and daily function.
- Patient-defined goals and psychological recovery from fear of attacks.
Recurrence and device lifecycle
- Repeat clinical and imaging review if pain returns or changes phenotype.
- Avoid automatic repetition of destructive treatment without reclassification.
- Corneal protection and ophthalmic review when V1 sensation is reduced.
- Programming, battery, lead and infection follow-up for stimulation systems.
- Revision, replacement or explant planning where required.
How Healwise supports the pathway
- Initial orientation and indication-specific document checklist.
- Structured attack history, trigger map, medication timeline and patient-goal preparation.
- MRI/DICOM, neuroradiology, neurological, dental, prior-procedure and sensory-outcome inventory.
- Identification of missing information before specialist review.
- Preparation of a concise trigeminal neuralgia or neuropathic facial pain case summary.
- Coordination of neurology, cranial or functional neurosurgery, neuroradiology, pain medicine, MS, orofacial pain or dental review where appropriate.
- Support with provider communication, consultation planning, translation, admission preparation, travel coordination and cost-process clarity if treatment abroad is clinically appropriate.
- Discharge, sensory-safety, medication, recurrence, device and referring-physician handover where applicable.
Important role boundaries
- Healwise does not diagnose trigeminal neuralgia or another facial pain condition.
- We do not prescribe, change or stop medication or provide emergency pain management.
- We do not determine whether a patient should receive microvascular decompression, an ablative procedure, radiosurgery or neuromodulation.
- We do not promise pain freedom, cure, permanent relief, preserved facial sensation or a specific recovery time.
- A visible vessel–nerve contact does not automatically establish the cause of pain or eligibility for surgery.
- Gasserian ganglion stimulation is a highly selective, limited-evidence salvage pathway—not an established routine treatment for classical trigeminal neuralgia.
- All diagnosis, eligibility, informed-consent, procedural and device-management decisions are the responsibility of licensed specialist teams.
The value of Healwise is structured case preparation and coordination: helping the right information reach the right specialist team and supporting continuity across diagnosis, treatment and follow-up.
Prepare a trigeminal neuralgia or facial pain case for specialist review
If you are a patient, family member or referring physician managing a complex facial pain case, Healwise can help clarify what documents are needed and coordinate the next specialist review pathway where appropriate.
